Market Exclusive

Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Results of Operations and Financial Condition

Cardinal Health, Inc. (NYSE:CAH) Files An 8-K Results of Operations and Financial Condition

Item 2.02: Results of Operations and Financial Condition

On May 1, 2017, Cardinal Health, Inc. (the “Company”) issued a
news release announcing its results for the quarter ended March 31,
2017. A copy of the news release is included as Exhibit 99.1 to
this report.
Item 7.01: Regulation FD Disclosure
During a webcast scheduled to be held at 8:30 a.m. Eastern time on
May 1, 2017, the Company’s Chairman and Chief Executive Officer
and Chief Financial Officer will discuss the Company’s results for
the quarter ended March 31, 2017>and outlook for the fiscal year
ending June 30, 2017. The slide presentation for the webcast will
be available on the Investors page at ir.cardinalhealth.com. An
audio replay of the webcast also will be available on the Investors
page at ir.cardinalhealth.com.
Item 9.01: Financial Statements and Exhibits
(d) Exhibits
Exhibit
Number
Exhibit Description
99.1
News release issued by the Company on May 1, 2017
announcing third-quarter results.

About Cardinal Health, Inc. (NYSE:CAH)
Cardinal Health, Inc. is a healthcare services and products company. The Company operates through two segments: Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, over-the-counter healthcare and consumer products. This segment also operates nuclear pharmacies and cyclotron facilities; provides pharmacy management services to hospitals, as well as medication therapy management and patient outcomes services to hospitals, other healthcare providers and payers, and provides services to healthcare companies. The Medical segment distributes a range of medical, surgical and laboratory products, and provides services to hospitals, ambulatory surgery centers, clinical laboratories and other healthcare providers. This segment also manufactures, sources and develops its own Cardinal Health brand medical and surgical products. It provides post-acute care management and transition services, and software to hospitals. Cardinal Health, Inc. (NYSE:CAH) Recent Trading Information
Cardinal Health, Inc. (NYSE:CAH) closed its last trading session down -0.55 at 72.59 with 3,348,092 shares trading hands.

Exit mobile version